RxDoctor Payments Data

Elizabeth Wilson, PA

Medical · Frederick, MDNPI 1457405615

Payments from drug & device makers

$2,694in general payments, 2019–2025

Across 138 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$428
  • Lilly USA, LLC$385
  • Boehringer Ingelheim$340
  • AstraZeneca$268
  • AbbVie$236
  • Pfizer$207
  • plus $830 from 14 others

What the payments were for

  • Food & beverage$2,694100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,694 in reported general payments places this provider in the 75th percentile of 543 medical providers in Maryland.

See all medical providers in Maryland

Medicare billing

Part B allowed, 2024
$73,916
Medicare patients
295
Services billed
1,103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide26$34,641
JardianceEmpagliflozin36$32,626
OzempicSemaglutide12$22,840
EliquisApixaban19$17,058
FarxigaDapagliflozin Propanediol11$16,085
Atorvastatin Calcium204$2,654
Rosuvastatin Calcium95$2,312
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate15$1,950
SynthroidLevothyroxine Sodium20$1,689
Losartan Potassium98$1,630
Risedronate Sodium20$1,484
Levothyroxine Sodium171$1,480
Duloxetine Hcl18$1,352
Metoprolol Succinate54$1,201
Doxepin Hcl13$1,112

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$385$34,64126 claims
Boehringer IngelheimJardiance$340$32,62636 claims
Novo NordiskOzempic$428$22,84012 claims
PfizerEliquis$207$17,05819 claims
AstraZenecaFarxiga$268$16,08511 claims
AbbVieSynthroid$236$1,68920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 543 medical providers in Maryland.

Other medical in Frederick

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →